Persisting thrombin activity in elderly patients with atrial fibrillation on oral anticoagulation is decreased by anti-inflammatory therapy with intensive cholesterol-lowering treatment.

van Kuilenburg, Janet

Persisting thrombin activity in elderly patients with atrial fibrillation on oral anticoagulation is decreased by anti-inflammatory therapy with intensive cholesterol-lowering treatment. [electronic resource] - Journal of clinical lipidology - 273-80 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1933-2874

10.1016/j.jacl.2011.05.003 doi


Administration, Oral
Aged
Aged, 80 and over
Anti-Inflammatory Agents--administration & dosage
Anticholesteremic Agents--administration & dosage
Anticoagulants--administration & dosage
Atorvastatin
Atrial Fibrillation--complications
Azetidines--administration & dosage
Biomarkers--analysis
Double-Blind Method
Drug Therapy, Combination
Ezetimibe
Female
Fibrinolytic Agents--administration & dosage
Heptanoic Acids--administration & dosage
Humans
Inflammation--drug therapy
Male
Pilot Projects
Pyrroles--administration & dosage
Thrombin--metabolism
Thrombosis--drug therapy